History
  • No items yet
midpage
In re Vioxx Products Liability Litigation
889 F. Supp. 2d 857
E.D. La.
2012
Read the full case

Background

  • MDL litigation involves Vioxx (Rofecoxib) marketed by Merck; Vioxx approved by FDA in 1999 and withdrawn in 2004 after safety data.
  • Elliott, California resident, alleges congestive heart failure from Vioxx use (2002–2004).
  • Elliott filed suit in 2006; case removed to MDL and later pursued through Vioxx Resolution Program, with eligibility issues.
  • Elliott’s bankruptcy petition, filed June 30, 2009, did not disclose her Vioxx claims; later she continued litigation and signed a Future Evidence Stipulation.
  • Merck moved for summary judgment based on judicial estoppel; Elliott sought extension to respond and possibly amend petition.
  • Court analyzes whether Elliott’s nondisclosure was inadvertent and whether amending petition could cure the disclosure failure.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether judicial estoppel bars Elliott’s Vioxx claims Elliott argues nondisclosure was inadvertent; no intentional misrepresentation. Merck asserts Elliott’s omission was a material, intentional concealment with motive to gain from claims. Merck's motion granted; judicial estoppel applies and bars Elliott's claims.
Whether Elliott’s nondisclosure was inadvertent Elliott contends lack of intent, good faith belief she would not recover. Merck argues strong motive to conceal; Love standard shows inadvertence rarely present. Nondisclosure was not inadvertent; motive to conceal established; no genuine issue.
Whether amendment of bankruptcy petition can save omitted claims Elliott seeks to amend petition post-disclosure to cure estoppel problem. Amending petitions cannot revive omitted claims under Love and related Fifth Circuit precedent. Amendment cannot save the claim; omission remains fatal.
Whether an innocent trustee may pursue the omitted claim Trustee may pursue for creditors; Elliott argues possible benefit to creditors. Love and Reed limit trustee relief; plaintiff remains estopped. Trustee may pursue in some circumstances, but Elliott is estopped; dismissal without prejudice to trustee.

Key Cases Cited

  • In re Superior Crewboats, Inc., 374 F.3d 330 (5th Cir. 2004) (judicial estoppel requires clearly inconsistent positions, court acceptance, and noninadvertence)
  • In re Coastal Plains, Inc., 179 F.3d 197 (5th Cir. 1999) (bankruptcy debtor must disclose all assets; inadvertence analyzed by motive and knowledge)
  • Love v. Tyson Foods, Inc., 677 F.3d 258 (5th Cir. 2012) (amendment after disclosure is insufficient; motive to conceal supports estoppel)
  • Reed v. City of Arlington, 650 F.3d 571 (5th Cir. 2011) (innocent trustees may pursue for creditors; plaintiff estopped from recovery beyond creditors’ claims)
  • Burnes v. Pemco Aeroplex, Inc., 291 F.3d 1282 (11th Cir. 2002) (amendment cannot salvage nondisclosed claims; cited for contrast on disclosure timing)
Read the full case

Case Details

Case Name: In re Vioxx Products Liability Litigation
Court Name: District Court, E.D. Louisiana
Date Published: Sep 17, 2012
Citation: 889 F. Supp. 2d 857
Docket Number: MDL No. 1657
Court Abbreviation: E.D. La.